Fastest Growing Market:
The ampoules packaging market was valued at USD 3.96 billion in 2019, and it is expected to reach a value of USD 6.47 billion by 2024 at a CAGR of 8.52%, during the forecast period (2020-2025). Packaging is considered to be a critical stage in the manufacturing process, where the value addition process is one of the significant trends. The pharmaceutical industry has been using ampoules, especially glass, for a very long period, as a primary packaging solution.
- The surge in government initiatives to increase the adoption of generic products, government support to start a generic medical store, and a high prevalence of infectious diseases in the region are some factors that are anticipated to boost the generic injectables market in the region, during the forecast period.
- The emergence of plastic ampoules in the market has been to counter some of the concern relating to glass particles entering in the contents, during the breaking of the ampoules. This is expected to create an opportunity for the plastic ampoules manufacturers, and may be impacted by regulatory upgradations and standards present in the respective nation.
- Since the usage for ampoules is profoundly impacted by its demand in the pharmaceutical and life sciences’ end users, the market remains highly inclined toward these end-users for demand variations.
Scope of the Report
An ampoule is a small sealed glass or plastic sealed bottle, which is used to contain and preserve a sample, usually a solid or liquid. The ampoules packaging is being used in pharmaceutical, personal care, and cosmetic industries. Ampoules packaging is mostly used to protect liquid or solution from air and contaminants.
| By Material |
| ||Glass |
| ||Plastic |
| By End-user Industry |
| ||Pharmaceutical |
| ||Personal Care and Cosmetic |
| ||Other End-user Industries |
| Geography |
| || |
| North America |
|United States |
| || |
| Europe |
|United Kingdom |
|Rest of Europe |
| || |
| Asia-Pacific |
|Rest of Asia-Pacific |
| || |
| Latin America |
|Rest of Latin America |
| || |
| Middle East & Africa |
|Saudi Arabia |
|Rest of Middle East & Africa |
Report scope can be customized per your requirements. Click here.
Key Market Trends
Glass Ampoules Packaging to Hold a Significant Share
- In glass ampoules, medication is only in contact with glass, and the packaging is 100% tamper-proof. Therefore, over the years, these ampoules have been widely used in packaging injection drugs.
- For instance, Helixor, which contains Mistletoe therapy and is an integral part of integrative oncology, uses glass ampoules to maintain the characteristics of the medicine.
- In the case of cancer treatment, the chemotherapy, which includes traditional chemotherapeutic agents that are cytotoxic, requires glass ampoules. According to WHO, the cytotoxic medicines, such as calcium folinate, are mostly packed in an injection 3 mg/ml in 10‐ml ampoule. Therefore, to maintain the properties of the medications, glass is a preferred material.
- Furthermore, according to Gerresheimer, the glass packaging as primary material had recently increased in 2018, after witnessing a downfall in 2017.
- Gerresheimer has two plants at its site in the Indian city of Kosamba. The recently constructed Gerresheimer plant, in 2019, manufactures vials and ampoules for the pharmaceutical industry using tubular glass, while Neutral Glass makes molded glass products for pharmaceutical applications, and, only very recently, put a new high-performance furnace into operation.
To understand key trends, Download Sample Report
Latin America Accounts for Significant Share
- In Latin America, the market growth is impacted, as the countries are proactively working to reduce these counterfeit medicine, vaccines, and drugs from reaching the consumers.
- Brazil, for instance, is among the most prominent pharmaceutical markets in the region, with projections estimating it to emerge as a significant player on the global level. Brazil’s pharmaceutical business is now positioned as the sixth in the world and is projected to be in the top five, by 2021.
- Similarly, Mexico is globally positioned on 11th rank, on the list of countries in the pharmaceutical market. On the other hand, Argentina is considered the third-largest market in the region. These countries with the promising future of the pharmaceutical industry present a high opportunity for ampoules.
- Moreover, Latin America’s geriatric base is increasing rapidly. In 2010, 10% of the region’s population was above 60 years, and by the end of 2040, this number is estimated to more than double, reaching 21%, according to Pharmaphorum. With this increasing aging population, chronic diseases are principally driven, because over 80% of adults aged over 60 years have at least one chronic disease.
- The 2014 World Diabetes Day in Mexico City, which is a model for the kind of prevention the region needs, and the International Diabetes Foundation (IDF), including more than 15,000 people, aim to educate the population about lifestyle choices and provided services, such as simplified blood sugar testing, healthy cooking workshops, and exercise classes, which is boosting the demand for glass ampoules.
To understand geography trends, Download Sample Report.
The ampoules packaging market is fragmented. The surge in government initiatives, and increasing demand for injectables and other medicines, provide lucrative opportunities in the ampoules packaging market. Overall, the competitive rivalry among existing competitors is high. Moving forward, expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand of ampoules packaging. Key players are Schott AG, Amposan SA, Gerresheimer AG, etc.
Some of the key developments in the area are:
- April 2019 - The technology group, SCHOTT, is investing BRL 50 million in its pharmaceutical tubing production in Rio de Janeiro, as part of its global growth strategy. As the demand in pharmaceutical industries is increasing, SCHOTT is contributing to manufacture 100% inspection of glass tubing to detect possible defects.
- March 2019 - Gerresheimer is investing a EUR 40-70 million in the new plant in the North Macedonian capital of Skopje, first in South-Eastern Europe. The plant is expected to initially manufacture medical plastic ampoules, prior to adding prefillable glass syringes lines.
Table Of Contents
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
2.1 Analysis Methodology
2.2 Research Phases
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Attractiveness - Porter's Five Force Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers/Consumers
4.2.3 Bargaining Power of Suppliers
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
4.3 Industry Value Chain Analysis
5. MARKET DYNAMICS
5.1 Introduction to Market Drivers and Restraints
5.2 Market Drivers
5.2.1 Demand for Tamper-proof Pharmaceutical Product Packaging
5.2.2 Government Regulations and Standards
5.3 Market Restraints
5.3.1 Concerns Regarding Dumping of Used Ampoules
6. MARKET SEGMENTATION
6.1 By Material
6.2 By End-user Industry
6.2.2 Personal Care and Cosmetic
6.2.3 Other End-user Industries
6.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 Rest of Asia-Pacific
6.3.4 Latin America
188.8.131.52 Rest of Latin America
6.3.5 Middle East & Africa
184.108.40.206 Saudi Arabia
220.127.116.11 Rest of Middle East & Africa
7. COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Schott AG
7.1.2 Amposan SA
7.1.3 Gerresheimer AG
7.1.4 Uhlmann Pac-Systeme GmbH & Co. KG
7.1.5 Stevanato Group
7.1.6 ESSCO Glass
7.1.7 AAPL Solutions
7.1.8 Global Pharmatech Pvt Ltd
7.1.9 James Alexander Corporation
7.1.10 Nipro Pharma Packaging International NV
*List Not Exhaustive
8. INVESTMENT ANALYSIS
9. MARKET OPPORTUNITIES AND FUTURE TRENDS